BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29024971)

  • 1. Early predictors of Guillain-Barré syndrome in the life course of women.
    Auger N; Quach C; Healy-Profitós J; Dinh T; Chassé M
    Int J Epidemiol; 2018 Feb; 47(1):280-288. PubMed ID: 29024971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort.
    Levison LS; Thomsen RW; Markvardsen LK; Christensen DH; Sindrup SH; Andersen H
    Pediatr Neurol; 2020 Jun; 107():57-63. PubMed ID: 32192820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
    JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Guillain-Barré syndrome in the province of Quebec.
    Deceuninck G; Boucher RM; De Wals P; Ouakki M
    Can J Neurol Sci; 2008 Sep; 35(4):472-5. PubMed ID: 18973064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of psychiatric disorders in Guillain-Barre syndrome: A nationwide, population-based, cohort study.
    Tzeng NS; Chang HA; Chung CH; Lin FH; Yeh CB; Huang SY; Chang CC; Lu RB; Kao YC; Yeh HW; Chiang WS; Chien WC
    J Neurol Sci; 2017 Oct; 381():88-94. PubMed ID: 28991722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mortality from Guillain-Barré syndrome in Bangladesh.
    Ishaque T; Islam MB; Ara G; Endtz HP; Mohammad QD; Jacobs BC; Islam Z
    J Peripher Nerv Syst; 2017 Jun; 22(2):121-126. PubMed ID: 28447405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.
    De Wals P; Deceuninck G; Boucher RM; Ouakki M
    Clin Infect Dis; 2008 Apr; 46(8):e75-7. PubMed ID: 18444843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000.
    Hughes RA; Charlton J; Latinovic R; Gulliford MC
    Arch Intern Med; 2006 Jun; 166(12):1301-4. PubMed ID: 16801513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of Guillain-Barré Syndrome].
    Yoshikawa H
    Brain Nerve; 2015 Nov; 67(11):1305-11. PubMed ID: 26560945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome in children.
    Sladky JT
    J Child Neurol; 2004 Mar; 19(3):191-200. PubMed ID: 15119480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Guillain-Barré syndrome and myasthenia gravis.
    Hsieh MY; Chan OW; Lin JJ; Lin KL; Hsia SH; Wang HS; Chiu CH
    Brain Dev; 2013 Oct; 35(9):865-9. PubMed ID: 23177060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and triggers of adult-onset Guillain-Barré syndrome in southwestern Finland 2004-2013.
    Sipilä JO; Soilu-Hänninen M
    Eur J Neurol; 2015 Feb; 22(2):292-8. PubMed ID: 25196425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of Guillain-Barré syndrome in Iceland: A population-based study.
    Hafsteinsdóttir B; Ólafsson E; Jakobsson F
    Acta Neurol Scand; 2018 Nov; 138(5):454-458. PubMed ID: 30019469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
    Stowe J; Andrews N; Wise L; Miller E
    Am J Epidemiol; 2009 Feb; 169(3):382-8. PubMed ID: 19033158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up.
    Granieri E; Andreasi NG; De Martin P; Govoni V; Castellazzi M; Cesnik E; Pugliatti M; Casetta I
    Neurol Sci; 2019 Mar; 40(3):603-609. PubMed ID: 30617450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015-2016.
    Salinas JL; Walteros DM; Styczynski A; Garzón F; Quijada H; Bravo E; Chaparro P; Madero J; Acosta-Reyes J; Ledermann J; Arteta Z; Borland E; Burns P; Gonzalez M; Powers AM; Mercado M; Solano A; Sejvar JJ; Ospina ML
    J Neurol Sci; 2017 Oct; 381():272-277. PubMed ID: 28991697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of childhood Guillain-Barré syndrome as a cause of acute flaccid paralysis in Honduras: 1989-1999.
    Molinero MR; Varon D; Holden KR; Sladky JT; Molina IB; Cleaves F
    J Child Neurol; 2003 Nov; 18(11):741-7. PubMed ID: 14696900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.